The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zheleznyakova I.A.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education

Rumyantseva E.I.

Center for Expertise and Quality Control of Medical Care

Volkova O.A.

Center for Expertise and Quality Control of Medical Care

Avyaeva T.S.

Center for Expertise and Quality Control of Medical Care

Sdvizhkova M.A.

Center for Expertise and Quality Control of Medical Care

Alexandrov I.A.

Center for Expertise and Quality Control of Medical Care

Vakhrusheva T.S.

Center for Expertise and Quality Control of Medical Care

Trifonova G.V.

Center for Expertise and Quality Control of Medical Care

Sidorova E.A.

Center for Expertise and Quality Control of Medical Care

Yakina A.S.

Center for Expertise and Quality Control of Medical Care

Azarova Ya.A.

Regional Clinical Oncology Dispensary

Bagrova S.G.

Blokhin National Cancer Research Center

Gladkov O.A.

Medical Oncology Center «EVIMED»

Dubovichenko D.M.

Arkhangelsk Regional Clinical Oncology Dispensary

Zamkova E.V.

Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary

Zukov R.A.

Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary;
Voino-Yasenetsky Krasnoyarsk State Medical University

Ivanova A.K.

St. Petersburg City Clinical Oncological Dispensary

Karabina E.V.

Tula Regional Oncology Dispensary

Karaseva V.V.

Pirogov Russian National Research Medical University

Kogoniya L.M.

Moscow Regional Research Clinical Institute («MONIKI»)

Kutukova S.I.

St. Petersburg City Clinical Oncological Dispensary;
Pavlov First St. Petersburg State Medical University

Laletina S.A.

Krasnoyarsk branch of SOGAZ-Med

Mishina A.V.

Sverdlovsk Regional Oncology Dispensary

Novik A.V.

Petrov National Medical Research Center of Oncology;
St. Petersburg State Pediatric Medical University

Novikova O.Yu.

Regional Clinical Oncology Center

Nosov D.A.

Central Clinical Hospital of the Presidential Administration

Ovchinnikova E.G.

Nizhny Novgorod Regional Clinical Oncology Dispensary

Orlova R.V.

St. Petersburg City Clinical Oncological Dispensary;
Saint Petersburg State University

Petkau V.V.

Sverdlovsk Regional Oncological Dispensary;
Ural State Medical University

Plykina A.A.

Russian Society of Clinical Oncology

Semiglazova T.Y.

N.N. Petrov National Medical Research Centre of Oncology;
I.I. Mechnikov North-West State Medical University

Somonova O.V.

Blokhin National Cancer Research Center;
Evdokimov Moscow State University of Medicine and Dentistry

Statsenko G.B.

Clinical Oncological Dispensary

Stenina M.B.

Blokhin National Cancer Research Center

Sytov A.V.

Blokhin National Cancer Research Center

Tkachenko E.V.

Petrov National Medical Research Center of Oncology

Tryakin A.A.

Blokhin National Cancer Research Center

Fateeva A.V.

Loginov Moscow Clinical Scientific Center

Feoktistova P.S.

Mechnikov North-West State Medical University

Khudorozhkova N.P.

Sverdlovsk Regional Oncology Dispensary

Tjulandin S.A.

Blokhin National Cancer Research Center

Omelyanovskiy V.V.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education;
Research Financial Institute;
Semashko National Research Institute of Public Health

Cost of supportive cancer care in the Russian Federation. Part 1

Authors:

Zheleznyakova I.A., Rumyantseva E.I., Volkova O.A., Avyaeva T.S., Sdvizhkova M.A., Alexandrov I.A., Vakhrusheva T.S., Trifonova G.V., Sidorova E.A., Yakina A.S., Azarova Ya.A., Bagrova S.G., Gladkov O.A., Dubovichenko D.M., Zamkova E.V., Zukov R.A., Ivanova A.K., Karabina E.V., Karaseva V.V., Kogoniya L.M., Kutukova S.I., Laletina S.A., Mishina A.V., Novik A.V., Novikova O.Yu., Nosov D.A., Ovchinnikova E.G., Orlova R.V., Petkau V.V., Plykina A.A., Semiglazova T.Y., Somonova O.V., Statsenko G.B., Stenina M.B., Sytov A.V., Tkachenko E.V., Tryakin A.A., Fateeva A.V., Feoktistova P.S., Khudorozhkova N.P., Tjulandin S.A., Omelyanovskiy V.V.

More about the authors

Journal: Medical Technologies. Assessment and Choice. 2024;46(3): 93‑103

DOI: 10.17116/medtech20244603193

Read: 1482 times

Download PDF (RU)
Contact the author
Table of contents

COST OF SUPPORTIVE CANCER CARE IN THE RUSSIAN FEDERATION. PART 1
COST OF SUPPORTIVE CANCER CARE IN THE RUSSIAN FEDERATION. PART 1

To cite this article:

Zheleznyakova IA, Rumyantseva EI, Volkova OA, et al. . Cost of supportive cancer care in the Russian Federation. Part 1. Medical Technologies. Assessment and Choice. 2024;46(3):93‑103. (In Russ.)
https://doi.org/10.17116/medtech20244603193

Подписка 2026 Медицинские технологии. Оценка и выбор (Medical Technologies. Assessment and Choice)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Cost of supportive cancer care in the Russian Fede­ration. Part 2. Medi­cal Technologies. Asse­ssment and Choice. 2024;(4):63-73
Orga­nization and payment for mole­cular gene­tic analysis in patients with certain mali­gnancies in the constituent enti­ties of the Russian Fede­ration. Medi­cal Technologies. Asse­ssment and Choice. 2025;(1):36-50
Changes in diagnosis-related group payment model in the Russian Fede­ration in 2025. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):18-30
Approaches to the digi­tization of clinical guidelines. Medi­cal Technologies. Asse­ssment and Choice. 2025;(2):39-47
Oral cavity cancer epidemiology in men and women in the Sibe­rian Fede­ral District. Russian Journal of Preventive Medi­cine. 2024;(11):46-53
History creates man, and man creates history. On the 125th anni­versary of the P.A. Herzen Moscow Onco­logy Research Institute. P.A. Herzen Journal of Onco­logy. 2024;(6):5-11
Use of a new tetrapeptide analgesic at the stages of anti­tumor therapy. P.A. Herzen Journal of Onco­logy. 2024;(6):23-32
Primary outcomes after major anatomical liver rese­ctions in infa­nts at the National Children’s Medi­cal Center. Piro­gov Russian Journal of Surgery. 2025;(4):86-94
Dyna­mics of the main indi­cators of medi­cal care to the popu­lation of the Russian Fede­ration for the period 1993—2023 in the “Oncology” profile. P.A. Herzen Journal of Onco­logy. 2025;(3):71-77
Prevention and treatment of dermal toxi­city in children receiving anti-tumor radiation. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):470-480
Abstract:

OBJECTIVE

Modeling of annual cost of supportive therapy for malignant neoplasms in accordance with the guidelines of the All-Russian public organization “Russian Society of Clinical Oncology” (RUSSCO).

MATERIAL AND METHODS

The main material for modelling the cost of treatment were drug regimens presented in the RUSSCO guidelines for the following complications: chronic viral hepatitis B, hormone-mediated side effects, bone tissue pathology, immune-mediated side effects, mucositis, infusion reactions, thromboembolic complications, chronic pain syndrome, anorexia-cachexia syndrome, as well as enzyme replacement therapy for pancreatic cancer and nutritional support. To calculate population receiving anticancer drug therapy, we used data on medical billing registry database (2022). This database contains information on the number of completed cases of anticancer drug therapy and the number of appropriate patients. During the modeling, we hypothetically divided financing depending on the profiles of medical care and sources of funding.

RESULTS

The most expensive cases (87.2% of overall requirement) are treatment of bone lesions (5.532.288.615.94 rubles), thromboembolic complications (5.973.880.025.31 rubles), chronic pain syndrome (6.309.163.258.86 rubles) and nutritional support (7.009.301.585.00 rubles). Approximately 75% of the estimated funding is for «oncology» profile, i.e. treatment of complications will take place during chemotherapy period. In the current model, 47% of funding goes from the state programs of free drug supply, 28% from compulsory medical insurance to cover stay at the day and 24-hour hospitals, 23% from personal patients’ expenses.

CONCLUSION

Modeling of supportive cancer therapy cost can underlie changes in medical care payment system.

Keywords:

supportive cancer care
oncology
payment for medical care
anticancer drug treatment

Authors:

Zheleznyakova I.A.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education

Rumyantseva E.I.

Center for Expertise and Quality Control of Medical Care

Volkova O.A.

Center for Expertise and Quality Control of Medical Care

Avyaeva T.S.

Center for Expertise and Quality Control of Medical Care

Sdvizhkova M.A.

Center for Expertise and Quality Control of Medical Care

Alexandrov I.A.

Center for Expertise and Quality Control of Medical Care

Vakhrusheva T.S.

Center for Expertise and Quality Control of Medical Care

Trifonova G.V.

Center for Expertise and Quality Control of Medical Care

Sidorova E.A.

Center for Expertise and Quality Control of Medical Care

Yakina A.S.

Center for Expertise and Quality Control of Medical Care

Azarova Ya.A.

Regional Clinical Oncology Dispensary

Bagrova S.G.

Blokhin National Cancer Research Center

Gladkov O.A.

Medical Oncology Center «EVIMED»

Dubovichenko D.M.

Arkhangelsk Regional Clinical Oncology Dispensary

Zamkova E.V.

Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary

Zukov R.A.

Kryzhanovsky Krasnoyarsk Regional Clinical Oncology Dispensary;
Voino-Yasenetsky Krasnoyarsk State Medical University

Ivanova A.K.

St. Petersburg City Clinical Oncological Dispensary

Karabina E.V.

Tula Regional Oncology Dispensary

Karaseva V.V.

Pirogov Russian National Research Medical University

Kogoniya L.M.

Moscow Regional Research Clinical Institute («MONIKI»)

Kutukova S.I.

St. Petersburg City Clinical Oncological Dispensary;
Pavlov First St. Petersburg State Medical University

Laletina S.A.

Krasnoyarsk branch of SOGAZ-Med

Mishina A.V.

Sverdlovsk Regional Oncology Dispensary

Novik A.V.

Petrov National Medical Research Center of Oncology;
St. Petersburg State Pediatric Medical University

Novikova O.Yu.

Regional Clinical Oncology Center

Nosov D.A.

Central Clinical Hospital of the Presidential Administration

Ovchinnikova E.G.

Nizhny Novgorod Regional Clinical Oncology Dispensary

Orlova R.V.

St. Petersburg City Clinical Oncological Dispensary;
Saint Petersburg State University

Petkau V.V.

Sverdlovsk Regional Oncological Dispensary;
Ural State Medical University

Plykina A.A.

Russian Society of Clinical Oncology

Semiglazova T.Y.

N.N. Petrov National Medical Research Centre of Oncology;
I.I. Mechnikov North-West State Medical University

Somonova O.V.

Blokhin National Cancer Research Center;
Evdokimov Moscow State University of Medicine and Dentistry

Statsenko G.B.

Clinical Oncological Dispensary

Stenina M.B.

Blokhin National Cancer Research Center

Sytov A.V.

Blokhin National Cancer Research Center

Tkachenko E.V.

Petrov National Medical Research Center of Oncology

Tryakin A.A.

Blokhin National Cancer Research Center

Fateeva A.V.

Loginov Moscow Clinical Scientific Center

Feoktistova P.S.

Mechnikov North-West State Medical University

Khudorozhkova N.P.

Sverdlovsk Regional Oncology Dispensary

Tjulandin S.A.

Blokhin National Cancer Research Center

Omelyanovskiy V.V.

Center for Expertise and Quality Control of Medical Care;
Russian Medical Academy of Continuous Professional Education;
Research Financial Institute;
Semashko National Research Institute of Public Health

Received:

16.05.2024

Accepted:

10.06.2024

Close metadata

References:

  1. Miranda-Filho A, Bray F, Charvat H, Rajaraman S, Soerjomataram I. The world cancer patient population (WCPP): An updated standard for international comparisons of population-based survival. Cancer Epidemiology. 2020;69:101802. https://doi.org/10.1016/j.canep.2020.101802
  2. Protokoly klinicheskikh rekomendacij podderzhivayushhej terapii v onkologii. 2023. Accessed June 20, 2024. (In Russ.). https://rassc.org/ru/recommendations
  3. Elting LS, Shih YC. The economic burden of supportive care of cancer patients. Supportive Care in Cancer. 2004;12(4):219-226.  https://doi.org/10.1007/s00520-003-0513-1
  4. Anaissie E, Mink T. The cancer supportive care model: a patient-partnered paradigm shift in health care delivery. Journal of Participatory Medicine. 2011;3:e26. 
  5. Gevorkov AR, Bojko AV, Bolotina LV, Shashkov SV. Supportive care is mandatory for successful radiotherapy and chemoradiotherapy in patients with head and neck tumors. P.A. Herzen Journal of Oncology. 2018;7(3):75-84. (In Russ.). https://doi.org/10.17116/onkolog20187375
  6. Starchenko AA. Failure of the oncologist from the accompanying and supportive therapy means the rendering of services not meeting the safety requirements of oncopatients. Menedzher zdravookhraneniya. 2019;(2):59-67. (In Russ.).
  7. Plakhotnik OS, Trifonova GV, Zheleznyakova IA, Mazurov AM, Volkova OA, Avyaeva TS, et al. Medical Technologies. Assessment and Choice. 2023;(2):8-22. (In Russ.). https://doi.org/10.17116/medtech2023450218
  8. Anemiya pri zlokachestvennykh novoobrazovaniyakh. Klinicheskie rekomendacii. 2020. Accessed June 20, 2024. (In Russ.). https://cr.minzdrav.gov.ru/recomend/624_1
  9. Prakticheskie rekomendacii po profilaktike i lecheniyu oslozhneniy zlokachestvennykh opukholey i protivoopuxolevoy lekarstvennoy terapii. Rossiyskoe obshhestvo klinicheskoy onkologii, 2023. Accessed June 20, 2024. (In Russ.). https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=12053
  10. Sostoyanie onkologicheskoy pomoshhi naseleniyu v 2022 godu. 2023. Accessed June 20, 2024. (In Russ.). https://oncology-association.ru/wp-content/uploads/2023/08/sop-2022-el.versiya_compressed.pdf
  11. Brooks GA, Landrum MB, Kapadia NS, Wolf R, Parekh SJ, Keating NL. Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment. Journal of Clinical Oncology. 2022;40(16):1763-1771. https://doi.org/10.1200/JCO.21.02342
  12. O’Brien JA, Caro JJ. Direct medical cost of managing deep vein thrombosis according to the occurrence of complications. Pharmacoeconomics. 2002;20(9):603-615.  https://doi.org/10.2165/00019053-200220090-00004
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.